Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
Drug Metabolism and Personalized Therapy
|
January 12, 2016
Clinical implementation of pharmacogenetics
Xandra García-González, Teresa Cabaleiro, María José Herrero, et al.
International Journal of Oncology
|
October 9, 2002
Evaluation of NQO1 gene expression and variant allele in human NSCLC tumors and matched normal lung tissue
Jill M Kolesar, Stuart C Pritchard, Keith M Kerr, et al.
Proceedings. American Statistical Association. Annual Meeting
|
January 11, 2019
Ex-Vivo Modeling for Heritability Assessment and Genetic Mapping in Pharmacogenomics
Alison Motsinger-Reif, Chad Brown, Tammy Havener, et al.
Pharmacogenetics and Genomics
|
February 13, 2010
Cytochrome P450 2C9-CYP2C9
Derek Van Booven, Sharon Marsh, Howard McLeod, et al.
Pharmacogenetics and Genomics
|
November 5, 2010
Doxorubicin pathways: pharmacodynamics and adverse effects
Caroline F Thorn, Connie Oshiro, Sharon Marsh, et al.
The Oncologist
|
October 16, 2009
NCCTG Study N9741: leveraging learning from an NCI Cooperative Group phase III trial
Richard M Goldberg, Daniel J Sargent, Roscoe F Morton, et al.
Plos One
|
April 15, 2014
Germline variation in colorectal risk Loci does not influence treatment effect or survival in metastatic colorectal cancer
Hanna K Sanoff, Lindsay A Renfro, Pradeep Poonnen, et al.
Pharmacological Reviews
|
December 30, 2009
Pharmacogenomic discovery using cell-based models
Marleen Welsh, Lara Mangravite, Marisa Wong Medina, et al.
Oncology (Williston Park, N.Y.)
|
February 3, 2005
Cisplatin, fluorouracil, celecoxib, and RT in resectable esophageal cancer: preliminary results
Ramaswamy Govindan, Howard McLeod, Prasad Mantravadi, et al.
Pharmacogenetics and Genomics
|
June 16, 2009
Platinum pathway
Sharon Marsh, Howard McLeod, Eileen Dolan, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
Drug Metabolism and Personalized Therapy
|
January 12, 2016
Clinical implementation of pharmacogenetics
Xandra García-González, Teresa Cabaleiro, María José Herrero, et al.
International Journal of Oncology
|
October 9, 2002
Evaluation of NQO1 gene expression and variant allele in human NSCLC tumors and matched normal lung tissue
Jill M Kolesar, Stuart C Pritchard, Keith M Kerr, et al.
Proceedings. American Statistical Association. Annual Meeting
|
January 11, 2019
Ex-Vivo Modeling for Heritability Assessment and Genetic Mapping in Pharmacogenomics
Alison Motsinger-Reif, Chad Brown, Tammy Havener, et al.
Pharmacogenetics and Genomics
|
February 13, 2010
Cytochrome P450 2C9-CYP2C9
Derek Van Booven, Sharon Marsh, Howard McLeod, et al.
Pharmacogenetics and Genomics
|
November 5, 2010
Doxorubicin pathways: pharmacodynamics and adverse effects
Caroline F Thorn, Connie Oshiro, Sharon Marsh, et al.
The Oncologist
|
October 16, 2009
NCCTG Study N9741: leveraging learning from an NCI Cooperative Group phase III trial
Richard M Goldberg, Daniel J Sargent, Roscoe F Morton, et al.
Plos One
|
April 15, 2014
Germline variation in colorectal risk Loci does not influence treatment effect or survival in metastatic colorectal cancer
Hanna K Sanoff, Lindsay A Renfro, Pradeep Poonnen, et al.
Pharmacological Reviews
|
December 30, 2009
Pharmacogenomic discovery using cell-based models
Marleen Welsh, Lara Mangravite, Marisa Wong Medina, et al.
Oncology (Williston Park, N.Y.)
|
February 3, 2005
Cisplatin, fluorouracil, celecoxib, and RT in resectable esophageal cancer: preliminary results
Ramaswamy Govindan, Howard McLeod, Prasad Mantravadi, et al.
Pharmacogenetics and Genomics
|
June 16, 2009
Platinum pathway
Sharon Marsh, Howard McLeod, Eileen Dolan, et al.
Page
of 5